Finally, in repeated measures 2-way ANOVA analyses, TNF+ cell frequencies in R848- and IgG-IC+R848-stimulated naive or IgMhi MZ-like B cells were not significantly different between controls and patients with CIS or MS, or control females and female patients with CIS or MS (not shown). This evidence concerns the gene TNF and myeloid sarcoma.